Review – H. pylori and non-malignant diseases
The article considers the role of Helicobacter pylori (H. pylori) in the formation and progression of non-malignant diseases of the upper gastrointestinal tract and reviews the results of studies published in the period from April 2023 to May 2024. The association of H. pylori with gastroesophageal...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2024-09-01
|
| Series: | Microbiota in Health and Disease |
| Subjects: | |
| Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1036.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560920643338240 |
|---|---|
| author | D. Bordin M. Livzan O. Gaus S. Mozgovoi |
| author_facet | D. Bordin M. Livzan O. Gaus S. Mozgovoi |
| author_sort | D. Bordin |
| collection | DOAJ |
| description | The article considers the role of Helicobacter pylori (H. pylori) in the formation and progression of non-malignant diseases of the upper gastrointestinal tract and reviews the results of studies published in the period from April 2023 to May 2024. The association of H. pylori with gastroesophageal reflux disease remains controversial. However, eradication therapy has no significant effect on the formation of Barrett’s esophagus. There is an inverse relationship between H. pylori infection and the prevalence of eosinophilic esophagitis. H. pylori is still the main cause of chronic gastritis, which in some patients is accompanied by dyspepsia syndrome. Eradication of H. pylori can significantly improve morphologic features of atrophic gastritis and the severity of intestinal metaplasia at an early stage. The increased risk of gastric cancer in patients with autoimmune gastritis may be the result of previously unrecognized H. pylori infection. Against the background of a general trend towards a decrease in the prevalence of H. pylori-associated peptic ulcer disease, there is an increase in the proportion of drug-induced peptic ulcer disease, particularly among the older age group. |
| format | Article |
| id | doaj-art-c1c4720779494bdb87a6288ef39a247b |
| institution | Kabale University |
| issn | 2704-8845 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Verduci Editore |
| record_format | Article |
| series | Microbiota in Health and Disease |
| spelling | doaj-art-c1c4720779494bdb87a6288ef39a247b2025-01-03T10:30:12ZengVerduci EditoreMicrobiota in Health and Disease2704-88452024-09-01610.26355/mhd_20249_10361036Review – H. pylori and non-malignant diseasesD. Bordin0M. Livzan1O. Gaus2S. Mozgovoi3A.S. Loginov Moscow Clinical Scientific Center, Moscow, RussiaOmsk State Medical University, Omsk, RussiaOmsk State Medical University, Omsk, Russia, Omsk State Medical University, Omsk, RussiaThe article considers the role of Helicobacter pylori (H. pylori) in the formation and progression of non-malignant diseases of the upper gastrointestinal tract and reviews the results of studies published in the period from April 2023 to May 2024. The association of H. pylori with gastroesophageal reflux disease remains controversial. However, eradication therapy has no significant effect on the formation of Barrett’s esophagus. There is an inverse relationship between H. pylori infection and the prevalence of eosinophilic esophagitis. H. pylori is still the main cause of chronic gastritis, which in some patients is accompanied by dyspepsia syndrome. Eradication of H. pylori can significantly improve morphologic features of atrophic gastritis and the severity of intestinal metaplasia at an early stage. The increased risk of gastric cancer in patients with autoimmune gastritis may be the result of previously unrecognized H. pylori infection. Against the background of a general trend towards a decrease in the prevalence of H. pylori-associated peptic ulcer disease, there is an increase in the proportion of drug-induced peptic ulcer disease, particularly among the older age group.https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1036.pdfhelicobacter pylorigastroesophageal reflux diseaseeosinophilic esophagitischronic gastritisautoimmune gastritispeptic ulcerdyspepsiabariatric surgery. |
| spellingShingle | D. Bordin M. Livzan O. Gaus S. Mozgovoi Review – H. pylori and non-malignant diseases Microbiota in Health and Disease helicobacter pylori gastroesophageal reflux disease eosinophilic esophagitis chronic gastritis autoimmune gastritis peptic ulcer dyspepsia bariatric surgery. |
| title | Review – H. pylori and non-malignant diseases |
| title_full | Review – H. pylori and non-malignant diseases |
| title_fullStr | Review – H. pylori and non-malignant diseases |
| title_full_unstemmed | Review – H. pylori and non-malignant diseases |
| title_short | Review – H. pylori and non-malignant diseases |
| title_sort | review h pylori and non malignant diseases |
| topic | helicobacter pylori gastroesophageal reflux disease eosinophilic esophagitis chronic gastritis autoimmune gastritis peptic ulcer dyspepsia bariatric surgery. |
| url | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1036.pdf |
| work_keys_str_mv | AT dbordin reviewhpyloriandnonmalignantdiseases AT mlivzan reviewhpyloriandnonmalignantdiseases AT ogaus reviewhpyloriandnonmalignantdiseases AT smozgovoi reviewhpyloriandnonmalignantdiseases |